AdaptX is a clinical management platform that utilizes real-time analytics and AI to enhance operational efficiency in hospitals and surgery centers. It enables clinical leaders to optimize patient flow and resource allocation, directly addressing challenges related to capacity, revenue, and quality of care.

BiomeSense has developed the GutLab technology for continuous, at-home monitoring of the human gut microbiome, utilizing AI-enabled bioinformatics to generate and analyze high-resolution microbiome data. This platform addresses the challenge of limited microbiome datasets by providing reliable, longitudinal insights that can inform personalized medicine and biomarker discovery.

Bits offers a digital credit card that enables users to build their credit scores by reporting monthly repayments to credit bureaus. This service addresses the challenge of establishing credit history for individuals who may lack access to traditional credit products.

Calorify provides the world's most accurate measurement of energy expenditure. This measurement is powered by advanced doubly labeled water technology. The company offers enterprise solutions for businesses seeking precise metabolic vital signs data.

Cove is a co‑living platform that offers fully furnished private rooms in curated Singapore properties, with utilities, high‑speed Wi‑Fi, housekeeping and maintenance bundled into a single monthly price. Users can book instantly online for flexible stay lengths—monthly or nightly—and filter listings by location, budget and amenities, while enjoying community events and shared spaces that foster a sense of belonging.

LanceDB is an open-source database designed for multimodal AI applications, enabling rapid vector search and advanced data retrieval from large-scale datasets. It addresses the challenges of managing and scaling AI data by providing a performant solution that integrates seamlessly with existing data pipelines and supports real-time analytics.

Provides a sexual wellness platform that combines e-commerce, educational resources, and community-driven forums to promote open discussions about sexuality, self-discovery, and acceptance. It addresses the stigma surrounding sexual health by offering products, expert insights, and a supportive space for users to explore and share experiences.

Flaus has developed a patent-pending electric flosser that utilizes sonic vibrations and real dental floss to enhance oral hygiene by making flossing faster and more comfortable, achieving a thorough clean in under one minute. This technology addresses the common issue of inadequate flossing, which contributes to gum disease and costly dental bills, by encouraging regular use through an ergonomic design that is easy to handle.

Lifeforce provides an all‑in‑one longevity medicine membership that combines at‑home blood testing of 50+ biomarkers, wearable data integration, and a proprietary algorithm to generate a Lifescore measuring health, quality of life, mortality risk, and aging rate. Members receive quarterly retests, telehealth consultations, and personalized guidance from board‑certified clinicians and health coaches to implement data‑driven therapies and track continuous improvement.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

The startup operates a zero-knowledge oracle network for Ethereum, utilizing zero-knowledge proofs to facilitate secure off-chain computation for tasks such as automation and machine learning inference. This technology enhances the functionality and reliability of smart contracts, enabling developers to create more sophisticated decentralized applications without compromising on trust or security.

Pangea Bio is a clinical-stage biotech company focused on developing transformative medicines for neurological and mental health disorders. The company's core research targets the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. Their lead candidate, OT-003, and subsequent pipeline assets are designed to address significant unmet needs in CNS diseases.

Paterna Biosciences focuses on developing solutions to address male infertility using adult stem cell technology. The company's sole focus is restoring fertility by utilizing the patient's own stem cells to potentially resolve underlying genetic disorders. This work is strictly limited to therapeutic applications for infertility and does not involve heritable trait modification.

Plan A offers a certified carbon management platform that enables businesses to measure, analyze, and reduce their greenhouse gas emissions while ensuring compliance with the Corporate Sustainability Reporting Directive (CSRD). By providing tailored decarbonization strategies and expert support, the platform helps companies achieve net-zero emissions and improve their sustainability performance.

Rorra develops a countertop water filtration system utilizing Enfinity™ electrokinetic nanofiber technology to effectively reduce over 50 harmful contaminants, including lead and PFAS, from tap water. This plumbing-free solution addresses the widespread issue of contaminated drinking water in the U.S., providing safe and clean water without the need for installation or electricity.

This company develops clinically validated, drug and hormone-free neurotechnology solutions for menstrual health issues. They offer neurostimulation devices and a CycleSync software application for symptom prediction and cycle management. The core value is providing non-invasive relief for period pain and mood symptoms by balancing brain activity across the menstrual cycle.

This startup provides network and classroom management software designed for educational institutions and businesses, focusing on cloud technology, device management, and data analytics. Their solutions enhance network reliability and security, enabling organizations to efficiently manage their digital infrastructure.

Somnee utilizes proprietary EEG+ technology and personalized transcranial alternating current stimulation (tACS) to enhance sleep quality by mapping individual brainwave patterns and delivering tailored neurostimulation. This clinical-grade headband helps users fall asleep 50% faster and improves sleep efficiency, addressing the widespread issue of inadequate sleep among adults.

STRIVE develops intelligent apparel that measures muscle strain and exertion, providing athletes with real-time insights into their neuromuscular health. This technology helps users optimize performance, enhance recovery, and reduce the risk of injuries by identifying physiological imbalances and training inefficiencies.

Superpower is an AI-driven platform that enhances social media engagement by enabling brands to respond to comments and direct messages 14.2 times faster while maintaining brand voice consistency. It addresses the challenge of slow response times and potential miscommunication by centralizing interactions across multiple platforms in a single dashboard.

Unblocked is a contextual knowledge platform that integrates with development tools to provide developers with immediate, expert-level answers about their codebase. By surfacing relevant documentation and discussions directly in their IDEs, Unblocked reduces the time spent searching for information, saving teams 1 to 2 hours per engineer each day.

Develops genetically engineered probiotics, including ZBiotics® Pre-Alcohol and Sugar-to-Fiber, using bioengineering techniques to modify _Bacillus subtilis_ strains. Pre-Alcohol breaks down acetaldehyde, a toxic byproduct of alcohol, in the gut to reduce hangover symptoms, while Sugar-to-Fiber converts dietary sugar into the prebiotic fiber levan, improving gut microbiome health.